Dermatomyositis clinical trials at UC Health
3 in progress, 2 open to new patients
-
Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)
open to eligible people ages 18 years and up
Prospective, Double-blind, Randomized, Placebo-Controlled Phase III Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis ("ProDERM study")
at UCLA UC Irvine
-
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
open to eligible people ages 18 years and up
Trial to Evaluate the Efficacy and Safety of Abatacept subcutaneous (SC) in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
at UCLA UC Irvine
-
Trial of IMO-8400 in Adult Patients With Dermatomyositis
Sorry, in progress, not accepting new patients
The purpose of this study is to determine how safe and effective IMO-8400 is in adults with dermatomyositis.
at UC Irvine
Last updated: